CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong
· Delayed Price · Currency is HKD 0.2900
+0.0100 (3.57%)
Jun 30, 2025, 3:52 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 123.12 million as of July 1, 2025. Its market cap has decreased by -10.83% in one year.
Market Cap
123.12M
Enterprise Value
256.44M
Revenue
90.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 123.12M, a decrease of -96.74%. That is a compound annual growth rate of -61.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 123.12M | 117.90% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 237.03B |
| Hansoh Pharmaceutical Group Company | 173.02B |
| JD Health International | 138.56B |
| Innovent Biologics | 127.75B |
| WuXi Biologics | 102.33B |
| Sino Biopharmaceutical | 94.79B |
| CSPC Pharmaceutical Group | 88.35B |
| Akeso | 83.03B |